• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • Cisema Webinar with US’s AdvaMed: Opportunities and Regulatory Implications in China’s Digital Healthcare Economy

Cisema Webinar with US’s AdvaMed: Opportunities and Regulatory Implications in China’s Digital Healthcare Economy

Friday, 23 April 2021 / Published in News, Webinars

Cisema Webinar with US’s AdvaMed: Opportunities and Regulatory Implications in China’s Digital Healthcare Economy

On May 25, 2021, Cisema and Advamed will cohost a webinar on China’s digital healthcare economy and relevant regulatory framework.

Mr. Hamish King, Chief Operating Officer of Cisema, will lead the discussion to present on the market opportunities and regulatory implications of the fast-growing digital healthcare sector in China. Covid-19 has only served to further accelerate favorable market tailwinds. Telehealth, AI and other key digital health trends in China will be discussed, and the regulatory framework analyzed.

Cisema Webinar: Opportunities and Regulatory Implications in China’s Digital Healthcare Economy

Date: May 25, 2021

Time: 11:00 PM – 12:00 PM (HKT)

Registration Link: TBA

Agenda topics will include:

1.     Digital Healthcare sector in China and recent updates

2.     Regulatory pathways for medical devices and IVDs with the China National Medical Products Administration (NMPA, formerly CFDA)

3.     Cyber security

4.     SaMD registration in China

5.     Alternative regulatory pathways

6.     Q&A

Be sure to stay till the end where our Cisema’s experts will answer your questions that could help equip you to access China’s digital health market.

What you can read next

avoid animal testing in Chinaweb-2023
How to avoid animal testing in China for cosmetics | Cisema Webinar
Automotive Implementation Rules for CCC-Certification Revised
china clinical application management
China Clinical Application Management on Restrictive Medical Technologies – Catalogue and Specifications (2022 Edition)

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • laser therapy devices

    Clinical evaluation of laser therapy devices – New guidelines issued

    Clinical evaluation of laser therapy devices ha...
  • dental implant system

    Clinical evaluation of dental implant systems in China – New guidelines issued

    Clinical evaluation of dental implant system ha...
  • China Medical Device Webinar

    China Medical Device Webinar with AdvaMed Accel for U.S. exporters

    The China Medical Device Webinar will be featur...
  • webinar_medical-device-market-authorisation

    Cisema presenting at FORUM Institut: Medical device marketing authorisation for advanced – Masterclass China

    Cisema is delighted to hold a Masterclass with ...
  • generative AI services

    China’s generative AI interim measures now in effect

    China’s generative AI interim measures fo...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP